MALLORY QUESENBERRY: Open Payments
NPI 1568009488 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,059 in 90 payments from 28 companies in 2025. Trend: 2023 $760 · 2024 $1,015 · 2025 $2,059
Food & beverage: $2,059
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $363 |
| ABBVIE INC. | 12 | $236 |
| PFIZER INC. | 14 | $188 |
| Novo Nordisk Inc | 13 | $170 |
| Phathom Pharmaceuticals, Inc. | 2 | $168 |
| Lilly USA, LLC | 6 | $118 |
| SANOFI-AVENTIS U.S. LLC | 2 | $90 |
| Ardelyx, Inc. | 3 | $80 |
| Organon LLC | 3 | $80 |
| Dexcom, Inc. | 3 | $75 |
Products named: FARXIGA, VOQUEZNA, MOUNJARO, UBRELVY, Ozempic, TZIELD, NURTEC ODT, IBSRELA.
Industry payments across MO — which companies pay providers there.
